The dark side of ‘shrinking girl summer'
Then came anger, not with Stokes but with the media and brands that propagate a culture of skinny worship. I was born with a rare physical disability and have spent years coming to terms with the way my body is. I look disabled, I have scars from operations and a spinal curve surgeons couldn't straighten, and I use mobility aids. To me, Stokes presents as an attractive, successful, healthy woman who is non-disabled (although this is her private business) with the good fortune to have two children. I wish Stokes and others could see themselves in that vein. Granted, it took me years to be happy in my own skin and see the strengths of my body, everything I've been through and the pleasure it can give and receive, but it's doable.
We are living in dark times when non-disabled women and men are wrecking their mental health and putting their physical health in danger with fad diets and weight-loss jabs, shrinking themselves to an ever-hungry and cold status to please others' gazes and get likes on TikTok and Instagram. As a society we should be ashamed that we are engendering this, putting people at risk of eating disorders, malnutrition and mental health issues.
We only have one body and if you're fortunate enough to have one that works properly, you've won the jackpot.Name and address supplied
Self-loathing, shame, isolation and the desire for slenderness are not an intrinsic or inevitable aspect of being fat, as features such as Rose Stokes' seem to suggest. They are caused by fatphobia. This has been ruthlessly exploited by weight-loss industries, including the contemporary manufacturers of GLP-1 drugs. These purveyors are not called to account when their products fail or harm their users. Instead, fat people are made to feel responsible. We should have tried harder.
For a more balanced view, I invite Guardian editors, writers and readers to consider a social movement that has been active for at least 50 years and which takes a critical view of the obesity‑industrial complex.
The scholarly field of fat studies and the public health model known as 'health at every size' are offshoots. There are many of us working in these areas, providing a more nuanced and hopeful understanding of fat subjectivity.Charlotte CooperLondon
Rose Stokes' article strikes a chord across the femisphere. I would add that body dysmorphia has never been confined to women whose bodies don't conform to skinny standards. The body-positivity movement liberated all women from these impossible strictures. It's no coincidence that as soon as it arrived, and women began to take up more and powerful space, drugs were pumped out to make sure we take less.Danuta KeanHastings, East Sussex
Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BreakingNews.ie
10 minutes ago
- BreakingNews.ie
More than third of women playing football and camogie experience urinary leakage
More than one third of women playing Gaelic football and camogie experience urinary leakage during training and match play, research has found. Urinary leakage – a form of incontinence – remains a hidden struggle for many female athletes, largely due to embarrassment and stigma, a report found. Advertisement Dublin City University's research, published in Science and Medicine in Football, explores how menstrual cycle-related symptoms, hormonal contraceptive use, and indicators of pelvic floor dysfunction affect players of ladies Gaelic football and camogie. Among players not using hormonal contraceptives, 97.7 per cent reported menstrual cycle–related symptoms, most commonly abdominal cramping (84 per cent) and fatigue (82.2 per cent). Around 85 per cent believe their menstrual cycle affects onfield performance, with 59 per cent indicating a negative impact. Dr David Nolan (DCU/PA) Approximately 37 per cent of athletes experienced urinary leakage during training or matches, suggesting potential pelvic floor concerns. A high proportion also experience urinary urgency (47.8 per cent) and genital pain (43.4 per cent). Advertisement Dr David Nolan, assistant professor of Sport and Exercise Sciences at the DCU School of Health and Human Performance, said urinary leakage is a current taboo in women's sports. He said: 'There's more and more data being gathered, more studies coming out showing that active young sports women are experiencing urinary leakage at a significant rate, very high prevalence in gymnastics, in strength sports. 'But now in field sports, you get more data that it's affecting up to one third of our players. 'From working in female sport myself, I knew there was a prevalence of it, but I didn't expect it to be that high. This is probably the issue of why it's not spoken about more, and why players probably don't speak about it as much as they themselves probably don't realise that it's as commonplace. Advertisement 'If they think that it's something that's not affecting their teammates as much as them, they're probably less likely to speak because they don't know how common it actually is.' He added: 'The common symptoms are the urinary leakage, then urinary urgency, so the strong desire to go to the bathroom. You can have prolapse within the vagina, and then you can have anal incontinence linked to it. 'The most common symptoms, though, would be the urine leakage and the urinary urgency. The sad and frustrating thing about them suffering in silence is with physiotherapy and just exercise interventions, we can significantly reduce those symptoms.' He said the effects can lead to women dropping out of their sport. Advertisement He added: 'We do have evidence to show that it's linked to drop out in sport and again, because there can be potential shame or stigma around it and a source of embarrassment. 'So players might, in extreme cases, drop out of sports, or be less motivated to train. It can occur mostly in high impact, high kind of stress sports and performance – so they might be hesitant to push themselves hard or to engage in intense activities for fear of of this embarrassment.' The new peer-reviewed study of ladies' Gaelic footballers and camogie players in Ireland has thrown new light on the issue. Some 455 female Gaelic games athletes across both club and inter-county level were surveyed. Advertisement The study asked players about their menstrual cycles, use of hormonal contraceptives, like the contraceptive pill, and any pelvic floor dysfunction symptoms. Firstly, the survey confirmed that menstrual-related symptoms are highly prevalent. Among players not using hormonal contraceptives, 97.7 per cent reported at least one menstrual-related symptom each month. The most common complaints were abdominal cramping (experienced by 84 per cent of players) and fatigue or low energy (82 per cent). Perhaps not surprisingly, a large proportion – about 59 per cent perceived a mostly negative impact on how they play, citing issues like pain, heavy bleeding, or sluggishness during certain cycle phases. The study also looked at hormonal contraceptives. Just over half of the Gaelic players (51.7 per cent) were on some form of hormonal contraception, with the pill by far the most popular choice (used by about 69 per cent). Some 62 per cent of the athletes using hormonal contraceptives reported side effects, including fatigue (37.2 per cent) and experiencing mood swings or low mood (35.0 per cent). About one in three contraceptive-users (31.6 per cent) even felt that their contraception was impacting their athletic performance. However, issues around the pelvic floor is an aspect of women's health that athletes and coaches rarely discuss, the research found. 'Pelvic floor dysfunction' is an umbrella term for problems like urinary incontinence (leakage), urgency (sudden intense need to go), or pelvic organ prolapse. The stereotype is that these issues only impact older women or those who have had children. In this research, the average age of players surveyed was just 23.6 years old, and most had likely never given birth as the average first-time mother in Ireland is 31.5. Despite this, a considerable number of these young athletes reported troubling pelvic floor symptoms. The authors behind the report recommend enhanced education and support for athletes, coaches, and support staff on menstrual health, contraceptives, and pelvic floor health – as well as individualised symptom management strategies, integrating physiological monitoring with athlete feedback.
Telegraph
40 minutes ago
- Telegraph
Lucy Letby ‘raised alarm over poor care of babies in her hospital'
Lucy Letby raised the alarm over the poor care of babies at the hospital in which she worked, new documents show. The former neo-natal nurse, 35, was convicted of the murder of seven children and the attempted murder of seven more at the Countess of Chester Hospital in a prosecution that has come under intense scrutiny. Letby has since appointed a new legal team who have submitted an application on her behalf to the Criminal Cases Review Commission, claiming that she is the victim of a miscarriage of justice. Mark McDonald, Letby's barrister, said that she was a 'hard working nurse who loved her job' and would never harm a child. He added: '[That] is why she would not let any fault pass. This was a neonatal unit in crisis and she consistently formally reported issues. 'She was a whistleblower – but instead of listening to her they went for her instead.' Mr McDonald said Letby was targeted for raising concerns, and an expert international panel recently concluded that no murders were committed and instead that the babies collapsed or died because of either poor care or natural causes. Lawyers for the families of Letby's victims previously rubbished the panel's findings as 'full of analytical holes' and 'a rehash' of the defence case heard at trial. The documents that reveal Letby's complaints were first reported by The Mail on Sunday. The records – known as Datix Admin and Management Forms – cover a number of medical emergencies in the unit in 2015 and 2016. The group that investigated Letby's complaints included Dr Stephen Brearey, who was one of two doctors who would later raise questions about whether she was 'purposely harming babies'. Lack of resources On June 30 2016, Letby used the system to report an incident a week earlier when a baby had suffered a 'sudden acute collapse requiring resuscitation', only for staff dealing with the emergency to find that the sodium bicarbonate infusion required to deal with the crisis was not available. Dr Brearey's investigating group recommended new measures to 'ensure adequate stock levels in future'. Letby filed a second report about another baby on the ward who had collapsed three hours after the first incident, saying that 'resources were not available on unit' to deal with the emergency. According to the Mail on Sunday, Dr Brearey later amended the incident form to state that the medical resources mentioned were not necessary to deal with the incident and in any case were not 'routinely kept on the unit' – but then conceded that because of 'a recent increase in usage' delivery would be arranged. Another report by Letby in June 2016 identified failures by doctors over the administration of intravenous medication. Dr Brearey's group concluded that nurses should check the equipment 'on an hourly basis' and that Dr Brearey would 'update new doctors at induction'. At Dr Brearey's request, Letby was removed from clinical duties the following month. Other reports by Letby included the 'unexpected death' of a baby in August 2015. However, it was concluded that 'neonatal care was appropriate... it is unlikely any changes in management would have prevented this sad outcome'. She also recorded the deterioration of an infant after ventilation records were not recorded for a 12-hour period and a 'chest drain complication' resulting from a lack of needles on the ward. Letby's case is now being considered by the Criminal Cases Review Commission, which is expected to report back before Christmas.
The Guardian
an hour ago
- The Guardian
Why antibiotics are like fossil fuels
In 1954, just a few years after the widespread introduction of antibiotics, doctors were already aware of the problem of resistance. Natural selection meant that using these new medicines gave an advantage to the microbes that could survive the assault – and a treatment that worked today could become ineffective tomorrow. A British doctor put the challenge in military terms: 'We may run clean out of effective ammunition. Then how the bacteria and moulds will lord it.' More than 70 years later, that concern looks prescient. The UN has called antibiotic resistance 'one of the most urgent global health threats'. Researchers estimate that resistance already kills more than a million people a year, with that number forecast to grow. And new antibiotics are not being discovered fast enough; many that are essential today were discovered more than 60 years ago. The thing to remember is that antibiotics are quite unlike other medicines. Most drugs work by manipulating human biology: paracetamol relieves your headache by dampening the chemical signals of pain; caffeine blocks adenosine receptors and as a result prevents drowsiness taking hold. Antibiotics, meanwhile, target bacteria. And, because bacteria spread between people, the challenge of resistance is social: it's as if every time you took a painkiller for your headache, you increased the chance that somebody else might have to undergo an operation without anaesthetic. That makes resistance more than simply a technological problem. But like that British doctor in 1954, we still often talk as if it is: we need to invent new 'weapons' to better defend ourselves. What this framing overlooks is that the extraordinary power of antibiotics is not due to human ingenuity. In fact, the majority of them derive from substances originally made by bacteria and fungi, evolved millions of years ago in a process of microbial competition. This is where I can't help thinking about another natural resource that helped create the modern world but has also been dangerously overused: fossil fuels. Just as Earth's geological forces turned dead plants from the Carboniferous era into layers of coal and oil that we could burn for energy, so evolution created molecules that scientists in the 20th century were able to recruit to keep us alive. Both have offered an illusory promise of cheap, miraculous and never-ending power over nature – a promise that is now coming to an end. If we thought of antibiotics as the 'fossil fuels' of modern medicine, might that change how we use them? And could it help us think of ways to make the fight against life-threatening infections more sustainable? The antibiotic era is less than a century old. Alexander Fleming first noticed the activity of a strange mould against bacteria in 1928, but it wasn't until the late 1930s that the active ingredient – penicillin – was isolated. A daily dose was just 60mg, about the same as a pinch of salt. For several years it was so scarce it was worth more than gold. But after production was scaled up during the second world war, it ended up costing less than the bottle it came in. This abundance did more than tackle infectious diseases. Just as the energy from fossil fuels transformed society, antibiotics allowed the entire edifice of modern medicine to be built. Consider surgery: cutting people open and breaking the protective barrier of the skin gives bacteria the chance to swarm into the body's internal tissues. Before antibiotics, even the simplest procedures frequently resulted in fatal blood poisoning. After them, so much more became possible: heart surgery, intestinal surgery, transplantation. Then there's cancer: chemotherapy suppresses the immune system, making bacterial infections one of the most widespread complications of treatment. The effects of antibiotics have rippled out even further: they made factory farming possible, both by reducing disease among animals kept in close quarters, and by increasing their weight through complex effects on metabolism. They're one of the reasons for the huge increase in meat consumption since the 1950s, with all its concomitant welfare and environmental effects. Despite the crisis of resistance, antibiotics remain cheap compared with other medicines. Partly – as with fossil fuels – this is because the negative consequences of their use (so-called externalities) are not priced in. And like coal, oil and gas, antibiotics lead to pollution. One recent study estimated that 31% of the 40 most used antibiotics worldwide enter rivers. Once they're out there, they increase levels of resistance in environmental bacteria: one study of soil from the Netherlands showed that the incidence of some antibiotic-resistant genes had increased by more than 15 times since the 1970s. Another source of pollution is manufacturing, particularly in countries such as India. In Hyderabad, where factories produce huge amounts of antibiotics for the global market, scientists have found that the wastewater contains levels of some antibiotics that are a million times higher than elsewhere. Like the climate crisis, antibiotic resistance has laid global inequalities bare. Some high-income countries have taken steps to decrease antibiotic use, but only after benefiting from their abundance in the past. That makes it hard for them to take a moral stand against their use in other places, a dilemma that mirrors the situation faced by post-industrial nations urging developing nations to forgo the economic benefits of cheap energy. This may be where the similarities end. While we look forward to the day when fossil fuels are phased out completely, that's clearly not the case with antibiotics, which are always going to be part of medicine's 'energy mix'. After all, most deaths from bacterial disease worldwide are due to lack of access to antibiotics, not resistance. What we are going to need to do is make our approach to development and use much more sustainable. Currently, many pharmaceutical companies have abandoned the search for new antibiotics: it's hard to imagine a more perfect anti-capitalist commodity than a product whose value depletes every time you use it. That means we need alternative models. One proposal is for governments to fund an international institute that develops publicly owned antibiotics, rather than relying on the private sector; another is to incentivise development with generously funded prizes for antibiotic discovery. And to address the issue of overuse, economists have suggested that health authorities could run 'subscription' models that remove the incentive to sell lots of antibiotics. In one pilot scheme in England, two companies are being paid a set amount per year by the NHS, regardless of how much of their product is actually used. Finally, we have to remember that antibiotics aren't the only game in town. Supporting other, 'renewable' approaches means we get to use the ones we do have for longer. Vaccines are vital to disease prevention – with every meningitis, diphtheria or whooping cough vaccine meaning a potential course of antibiotics forgone. And the 20th century's largest reductions in infectious disease occurred not because of antibiotics, but thanks to better sanitation and public health. (Even in the 2000s, the threat of MRSA was addressed with tried-and-tested methods such as handwashing and cleaning protocols – not new antibiotics.) Given that antibiotics themselves emerged unexpectedly, we should also be investing more in blue-skies research. Just as we no longer burn coal without a thought for the consequences, the era of carefree antibiotic use is now firmly in the past. In both cases, the idea that there wouldn't be a reckoning was always an illusion. But as with our slow waking up to the reality of the climate crisis, coming to appreciate the limits of our love affair with antibiotics may ultimately be no bad thing. Liam Shaw is a biologist at the University of Oxford, and author of Dangerous Miracle (Bodley Head). Being Mortal: Medicine and What Matters in the End by Atul Gawande (Profile, £11.99) Infectious: Pathogens and How We Fight Them by John S Tregoning (Oneworld, £10.99) Deadly Companions: How Microbes Shaped our History by Dorothy H Crawford (Oxford, £12.49)
